San Francisco, California
London, United Kingdom
CEPAC’s public deliberation of the evidence will provide clarity and guidance to clinicians, insurers, and policymakers confronted with decisions on how best to manage type 2 diabetes. Registration is free and open to the public, though a limited number of spaces are available.
For more information about CEPAC and further detail about the meeting, including voting questions and a meeting agenda, visit the CEPAC website.
Public Comment Process:
Written public comments on the draft assessment will be accepted by email via email@example.com until 5:00 PM ET on October 22, 2014.
Members of public wishing to deliver a public comment at the October 29, 2014 CEPAC meeting must email firstname.lastname@example.org by 5:00 PM ET October 24, 2014. Please note that slots for making a public comment are limited and will be assigned in the order that requests are received.
When & Where
Institute for Clinical and Economic Review
The Institute for Clinical and Economic Review (ICER) is an independent non-profit research institute that produces reports analyzing the evidence on the effectiveness and value of drugs and other medical services. ICER's reports include evidence-based calculations of prices for new drugs that accurately reflect the degree of improvement expected in long-term patient outcomes, while also highlighting price levels that might contribute to unaffordable short-term cost growth for the overall health care system.
ICER's reports incorporate extensive input from all stakeholders and are the subject of public hearings through three core programs: the California Technology Assessment Forum (CTAF), the Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC) and the New England Comparative Effectiveness Public Advisory Council (New England CEPAC). These independent panels review ICER's reports at public meetings to deliberate on the evidence and develop recommendations for how patients, clinicians, insurers, and policymakers can improve the quality and value of health care. For more information about ICER, please visit ICER's website.